Chronic Myelogenous Leukemia (CML): 5 Things to Know
Medscape - 23 Apr 2024Chronic Myelogenous Leukemia (CML): 5 Things to Know ...
慢性骨髄性白血病
Chronic Myelogenous Leukemia (CML): 5 Things to Know ...
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the ...
Nature.com - 29 Jan 2024Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the ... ...
Listening to the CML patient community
Novartis - 14 Feb 2024Listening to the CML patient community ...
Olverembatinib Added to NCCN Guidelines for CML
OncLive - 22 Jan 2024Olverembatinib Added to NCCN Guidelines for CML ...
If EPS Growth Is Important To You, CML Microsystems (LON:CML) Presents An Opportunity
Simply Wall St - 22 Apr 2024If EPS Growth Is Important To You, CML Microsystems (LON:CML) Presents An Opportunity ...
CML Occupies Day Hall as Board of Trustees Convenes in Ithaca
Cornell University The Cornell Daily Sun - 21 Mar 2024CML Occupies Day Hall as Board of Trustees Convenes in Ithaca ...
Olverembatinib Included in Newest Guidelines on Chronic Myeloid Leukemia (CML) Management from the National ...
PR Newswire - 16 Jan 2024Olverembatinib Included in Newest Guidelines on Chronic Myeloid Leukemia (CML) Management from the National ... ...
Asciminib Delivers Superior Responses in Phase 3 Ph+ CML Trial
Targeted Oncology - 08 Jan 2024Asciminib Delivers Superior Responses in Phase 3 Ph+ CML Trial ...
EP: 2.Ponatinib Dose-Ranging Data in Chronic-Phase CML
Cancer Network - 13 Oct 2023EP: 2.Ponatinib Dose-Ranging Data in Chronic-Phase CML ...
Ph+ CML: What's Different in the United States? And Why? - Chronic Myeloid Leukemia in Adults
Medpage Today - 10 Apr 2024Ph+ CML: What's Different in the United States? And Why? - Chronic Myeloid Leukemia in Adults ...
Activating p53 abolishes self-renewal of quiescent leukaemic stem cells in residual CML disease
Nature.com - 22 Jan 2024Activating p53 abolishes self-renewal of quiescent leukaemic stem cells in residual CML disease ...
Chronic Myelogenous Leukemia (CML): Practice Essentials, Background, Pathophysiology
Medscape Reference - 16 Oct 2023Chronic Myelogenous Leukemia (CML): Practice Essentials, Background, Pathophysiology ...
Asciminib Provides MMR Benefits vs SOC TKIs in Newly Diagnosed Ph+ CML
OncLive - 08 Jan 2024Asciminib Provides MMR Benefits vs SOC TKIs in Newly Diagnosed Ph+ CML ...
Treatment Updates and Key Highlights in Multiple Myeloma and CML
Cancer Network - 13 Nov 2023Treatment Updates and Key Highlights in Multiple Myeloma and CML ...
Life Without TKI Therapy: Is It Possible for Patients with CML? - Chronic Myeloid Leukemia in Adults
Medpage Today - 10 Apr 2024Life Without TKI Therapy: Is It Possible for Patients with CML? - Chronic Myeloid Leukemia in Adults ...
TERN-701 Receives FDA Orphan Drug Designation in CML
OncLive - 12 Mar 2024TERN-701 Receives FDA Orphan Drug Designation in CML ...
Fast Five Quiz: CML: When to Switch Therapy
Medscape Reference - 26 Jan 2024Fast Five Quiz: CML: When to Switch Therapy ...
Long-Term Results of the OPTIC Trial in CML
OncLive - 05 Mar 2024Long-Term Results of the OPTIC Trial in CML ...
Episode 5: Monitoring and Diagnostics in Chronic Myeloid Leukemia
Medscape - 28 Sep 2023Episode 5: Monitoring and Diagnostics in Chronic Myeloid Leukemia ...